A benefit–harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions

Autor: Bennett, Wendy L., Aschmann, Hélène E., Puhan, Milo A., Robbins, Craig W., Bayliss, Elizabeth A., Wilson, Renee, Mularski, Richard A., Chan, Wiley V., Leff, Bruce, Sheehan, Orla, Glover, Carol, Maslow, Katie, Armacost, Karen, Mintz, Suzanne, Boyd, Cynthia M.
Zdroj: In Journal of Clinical Epidemiology September 2019 113:92-100
Databáze: ScienceDirect